Featured speakers




More speakers
Name 4298_665073-fc> |
Title 4298_54ea79-83> |
Affiliation 4298_6d0424-9b> |
Saba Ghassemi 4298_6a4d36-67> |
Research Assistant Professor 4298_77138b-c4> |
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania 4298_116423-b9> |
Roddy O’Connor 4298_dda539-44> |
Research Assistant Professor 4298_80c628-10> |
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania 4298_32f00d-70> |
Michael Klichinsky 4298_5c4bf2-36> |
CSO 4298_01db9f-44> |
Carisma 4298_051d8c-1f> |
Gwendolyn binder 4298_a62abe-e8> |
President 4298_da1ea5-8f> |
Cabaletta Bio 4298_b9b2da-28> |
Jinmi (Mi Jin) 4298_0efe3d-fe> |
VP, Head of Drug Substance Development 4298_905e03-44> |
Spark Therapeutics 4298_b8778b-d7> |
Gaurav Chauhan 4298_ec6b7c-30> |
Founder and Principle Consultant 4298_3190d3-55> |
Chauhan BioConsulting 4298_91cdca-1f> |
Andrew Zydney 4298_7c07c5-66> |
Bayard D. Kunkle Chair and Professor of Chemical Engineering 4298_ad6385-c9> |
Penn State University 4298_01feed-69> |
Stephen Huges 4298_890f4f-12> |
CTO 4298_9ee531-65> |
Integrated Biorefining Corporation 4298_b58752-bd> |
Daniel Cohen 4298_3736d3-2e> |
Head of Vector Optimization 4298_fb89dd-9f> |
Spark Therapeutics 4298_2b97f7-58> |
Johannes C. M. van der Loo 4298_6d322c-21> |
Director, Clinical Vector Core 4298_edc6fc-75> |
The Childrenās Hospital of Philadelphia 4298_f5ce89-c2> |
Xiao Shelley Hu 4298_52d90b-0f> |
founder and president 4298_e7045a-0e> |
translational consulting llc 4298_026727-bf> |
Peixin Zhu 4298_cdcfd9-41> |
VP 4298_c03c9c-20> |
Verve Therapeutics 4298_bizgxp-0t> |
Chunyan He 4298_710669-14> |
Founder and CEO 4298_08b4b8-c2> |
GenAssist Therapeutics 4298_ogsjen-kp> |
Dennis Yu 4298_8b5eff-44> |
Founder and CEO 4298_707e76-4d> |
ValueBiologics 4298_jdai1k-2d> |
Zhenghong Gao 4298_1f8d56-8f> |
CTO 4298_c7d9ce-92> |
XGen Bio 4298_4sa6p5-ej> |
Elizabeth Ramsburg 4298_fc05b1-a0> |
VP, head of Neuroscience Research 4298_f80eb1-0b> |
Spark Therapeutics 4298_hyrlj1-y6> |
Steven Demarco 4298_842472-0b> |
Director, Toxicology 4298_8926db-64> |
Spark Therapeutics 4298_vrblv6-xv> |
Quan Jin 4298_6e3e58-4c> |
Asso. Director of Vector Engineering 4298_5d873d-fc> |
Spark Therapeutics 4298_xyrdye-sb> |
Daozhan Yu 4298_a55cc4-b0> |
CEO 4298_cc4c1b-f3> |
AAVnerGene 4298_yqsdt2-ow> |
Justin Percival 4298_11a223-56> |
Senior Director 4298_611b7f-7e> |
Rocket Pharmaceuticals 4298_1v49ix-fj> |
George Smith 4298_756035-73> |
Vice Chair and Professor 4298_d274dc-6b> |
Temple Univ 4298_i0mk59-g8> |
Prathap Nagaraja Shastri 4298_969caf-20> |
Director, Clinical Pharmacology and Pharmacometrics 4298_956363-6b> |
Johnson and Johnson 4298_jubna2-18> |
Kevin Hennegan 4298_a7b694-ea> |
Head of Advanced Therapies 4298_9e8668-1b> |
Quantum Regulatory Solutions 4298_yx6gs4-pw> |
Paul Mccracken 4298_8ed27b-64> |
Principal and Founder 4298_e7f91b-28> |
RadiaNova Consulting 4298_n2iswi-cp> |